CVS Health Corporation
CVS Healthcare Medical - Healthcare Plans NYSE
$77.92
$-0.77 (-0.98%)
Open: $78.77 | High: $78.86 | Low: $76.93 | Prev Close: $78.69
Market Cap: $99.13B
Volume: 7.1M | Avg: 8.7M
Last updated: March 09, 2026 at 02:01 AMInvestment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 437
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 56.06 |
| P/B Ratio | 1.32 |
| P/S Ratio | 0.25 |
| EPS | $1.39 |
| Beta | 0.46 |
| Shares Outstanding | 1.27B |
| 52-Week High | $85.15 |
| 52-Week Low | $58.35 |
| SMA 50 | $78.52 |
| SMA 200 | $73.49 |
| Dividend Yield | 3.41% |
| Annual Dividend | $2.66 |
| Next Earnings | April 29, 2026 12:30 PM ET |
Financial Ratios
| Gross Margin | 13.8% |
| Operating Margin | 1.2% |
| Net Margin | 0.4% |
| ROE | 2.3% |
| ROA | 0.7% |
| Debt/Equity | 1.24 |
| Current Ratio | 0.84 |
| Quick Ratio | 0.63 |
Balance Sheet
| Total Assets | $261.06B |
| Total Liabilities | $185.68B |
| Total Equity | $75.21B |
|
|
|
| Cash | $8.51B |
| Total Debt | $93.59B |
| Net Debt | $85.08B |
Income Statement
| Revenue | $402.07B |
| Gross Profit | $55.36B |
| Operating Income | $10.38B |
| Net Income | $1.77B |
|
|
|
| EBITDA | $9.86B |
| Revenue/Share | $316.59 |
Cash Flow
| Operating CF | $10.64B |
| CapEx | $2.83B |
| Free Cash Flow | $7.81B |
|
|
|
| Book Value/Share | $59.36 |
| Tangible Book/Share | $-28.03 |
| Equity/Share | $59.22 |
Technical Indicators
| RSI (14) | 48.02 Neutral |
| MACD |
0.29
Signal: 0.00
|
| Volatility | 47.22% |
| Trading Signal | Bullish |
Performance & Returns
| 1 Year | +24.12% |
| Sharpe Ratio | 0.87 Fair |
| Volatility (Ann.) | 29.03% Moderate |
| CVS (1Y) | +24.12% |
| S&P 500 (1Y) | +13.03% |
| Alpha (Excess Return) | +11.08% |
Sector Comparison (Healthcare)
| Metric | CVS | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 56.06 | 27.11 | 93% |
| P/B Ratio | 1.32 | -19.55 | 17% |
| ROE (%) | 2.34% | -9.33% | 21% |
| Net Margin (%) | 0.44% | 9.49% | 8% |
| Stock Score | 437 | 545.0 | 9% |
| 1Y Return (%) | +24.12 % | +7.83 % | 71% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVS | $77.92 | $79.40 | $78.70 | $77.77 | $78.46 | $73.48 | 48.02 | 0.29 | 47.22% | 1846294 | Weak Short | Bullish Stack |
Candlestick Patterns
There wasn't any recognizable pattern for the CVS stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| CVS | CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio? | Neutral | 247wallst.com | Read More |
| CVS | Why Is CVS Health (CVS) Down 1.7% Since Last Earnings Report? | Neutral | zacks.com | Read More |
| CVS | CVS Health's Aetna to Pay $117.7 Million to Resolve False Claims Act Allegations | Neutral | wsj.com | Read More |
| CVS | Sell Alert: 3 Popular REITs To Avoid | Neutral | seekingalpha.com | Read More |
| CVS | 2 Recession-Resistant Dividend Stocks to Buy Now | Neutral | fool.com | Read More |
Recent Insider Trading
No recent insider trading data available for CVS
Company Information
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
| CEO | J. David Joyner |
| Employees | 219000 |
| Country | US |
| IPO Date | 1996-11-20 |
| Exchange | NYSE |
| Website | https://www.cvshealth.com |
| Sector | Healthcare |
| Industry | Medical - Healthcare Plans |
Similar Stocks (Healthcare - Medical - Healthcare Plans)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category